MiPLATE Clinical Trial: Mirasol® Pathogen Reduction Treated Platelets The Mirasol® Pathogen Reduction Technology System (Terumo, BCT, Lakewood, CO) uses a combination of riboflavin (vitamin B2) and UV light… February 13, 2024
Platelet Transfusions and Increased Risk of Death or Neurodevelopmental Impairment in Preterm Infants Preterm infants are at an increased risk for intracranial hemorrhage, as many are thrombocytopenic (<150,000 platelets/µL). Although there is little… February 7, 2024
The Genealogy of Blood Cells Hematopoietic stem cells (HSCs) give rise to all types of blood cells through myeloid progenitor cell types (e.g., red blood… January 31, 2024
Pathogenesis of Antibody-Mediated TRALI by Complement Transfusion-related acute lung injury (TRALI) is a rare, life-threatening adverse transfusion reaction that is difficult to predict and treat. The… January 25, 2024
Prediction of Vasovagal Reactions in Whole Blood Donors Using a Scoring System Previous studies have identified risk factors for vasovagal reactions (VVRs) in blood donors, including young age, female sex, lower body… January 17, 2024
Deep Learning A.I. System for Platelet Management Platelet inventory management is challenging due to their short shelf-life and fluctuating demand. Researchers in Germany created a risk assessment… January 10, 2024
Low Alloimmunization Risk if No Antibodies Formed during First 20 RBC Transfused Units RBC transfusions are critical for many patients with sickle cell disease. Patients are at risk, however, of developing alloantibodies, which… January 4, 2024
